Status:
UNKNOWN
Metabolic Syndrome and Sims Score
Lead Sponsor:
Assiut University
Conditions:
Metabolic Syndrome , Sims Score and Pediatrics
Eligibility:
All Genders
7-17 years
Phase:
NA
Brief Summary
SiMSscore was used as a simple and accurate method for Quantifying Metabolic Syndrome in adults , Developed siMS score was calculated using formula: siMS score = 2\*Waist/Height + Gly/5.6 + Tg/1.7 + T...
Detailed Description
Metabolic Syndrome (MetS) is defined as a cluster of cardio metabolic risk factors that include central obesity low levels of high-density lipoprotein-cholesterol (HDL-C), hypertriglyceridemia, hypert...
Eligibility Criteria
Inclusion
- All obese patients aged from 7 to 17 years old.
Exclusion
- All obesechildren
- With endocrial and syndromatic obesity, (Endocrinal disease as hypothyroidism and Cushing's syndrome etc, syndromic obesity asPrader-Willi syndrome ,Alstrom-Hallgren syndrome, Bardet-Biedl syndrome, Beckwith-Wiedemansyndrome,etc…….)
- Children on medications that affect lipid profile that include (β-Blockers ,Amiodarone ,Loop diuretics, Thiazide diuretics (high dose) ,Sodium-glucose co-transporter 2 (SGLT2) inhibitors ,Steroid Hormones/Anabolic Steroids, Antiviral Therapy ,Immunosuppressants ,Centrally Acting Medications as Anticonvulsants).
Key Trial Info
Start Date :
December 15 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2022
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04680702
Start Date
December 15 2020
End Date
December 1 2022
Last Update
December 29 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Assuit Univesrity
Asyut, Egypt